Evolution and Variations of the Ovine Model of Spina Bifida

Abstract

Spina bifida is the most common congenital anomaly of the central nervous system and the first non-fatal fetal lesions to be addressed by fetal intervention. While research in spina bifida has been performed in rodent, non-human primate and canine models, sheep have been a model organism for the disease. This review summarizes the history of development of the ovine model of spina bifida, previous applications, and translation into clinical studies. Initially used by Meuli et al., fetal myelomeningocele defect creation and in utero repair demonstrated motor function preservation. The addition of myelotomy in this model can reproduce hindbrain herniation malformations, which is the leading cause of mortality and morbidity in humans. Since inception, the ovine models have been validated numerous times as the ideal large animal model for fetal repair, with both locomotive scoring and spina bifida defect scoring adding to the rigor of this model. The ovine model has been used to study different methods of myelomeningocele defect repair, the application of various tissue engineering techniques for neuroprotection and bowel and bladder function. The results of these large animal studies have been translated into human clinical trials including MOMS (Management of Meningocele Study) trial that established current standard of care for prenatal repair of spina bifida defects, and the ongoing trials including the CuRe (Cellular Therapy for In Utero Repair of Myelomeningocele) trial using a stem cell patch for repair. The advancement of these live saving and life altering therapy began in sheep models, and this notable model continues to be used to further the field including current work with stem cell therapy.